| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/31/2008 | WO2008091781A1 Reducing tumor growth |
| 07/31/2008 | WO2008091643A2 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 07/31/2008 | WO2008091620A2 Combination therapy comprising romidepsin and i.a. bortezomib |
| 07/31/2008 | WO2008091530A2 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 07/31/2008 | WO2008091222A1 Dll4 signaling inhibitors and uses thereof |
| 07/31/2008 | WO2008090960A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090884A1 Novel trifluoromethylphenyltetrahydrocinnoline derivative and pharmaceutical use thereof |
| 07/31/2008 | WO2008090850A1 Agent for enhancing the effect of anticancer agent |
| 07/31/2008 | WO2008090732A1 Pharmaceutical composition |
| 07/31/2008 | WO2008090717A1 Adam inhibitor |
| 07/31/2008 | WO2008090565A1 Novel thermodynamically stable polymorphic form-l of letrozole |
| 07/31/2008 | WO2008090356A1 Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity |
| 07/31/2008 | WO2008090355A2 Inhibitors of stem cells markers |
| 07/31/2008 | WO2008090353A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 07/31/2008 | WO2008090327A1 New combination for use in the treatment of cancer |
| 07/31/2008 | WO2008090177A2 Diagnosis of prostate cancer |
| 07/31/2008 | WO2008090081A1 Metal salophen complexes for prevention and treatment of cancer |
| 07/31/2008 | WO2008089674A1 Cyclohexenone extractant of antrodia camphorata |
| 07/31/2008 | WO2008089645A1 Fusion polypeptide inhibiting cell growth and use thereof |
| 07/31/2008 | WO2008089628A1 A nanoparticle of glucidamin for treating tumor and preparation method thereof |
| 07/31/2008 | WO2008089602A1 The tetracyclic anthraquinones possessing anti-cancer effect |
| 07/31/2008 | WO2008089594A1 Use of phthalide dipolymers for antitumor |
| 07/31/2008 | WO2008089581A1 Fused aromatic ptp-1b inhibitors |
| 07/31/2008 | WO2008089567A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089566A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008068507A3 2 -phenylamino, 6- (pyrid-3-yl) quinazoline derivatives as raf-protein kinase inhibitors in cancer treatment |
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008065428A3 Steroid sulphatase inhibitors for treating hormone dependent cancer |
| 07/31/2008 | WO2008065409A3 Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor |
| 07/31/2008 | WO2008065282A3 Substituted pyrazoles, compositions containing these, method of production and use |
| 07/31/2008 | WO2008065282A2 Substituted pyrazoles, compositions containing these, method of production and use |
| 07/31/2008 | WO2008061236A3 Sulfoximines as kinase inhibitors |
| 07/31/2008 | WO2008059068A3 Carbonyl-substituted titanocenes |
| 07/31/2008 | WO2008056188A3 Novel compounds and methods for their production |
| 07/31/2008 | WO2008051797A3 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 07/31/2008 | WO2008051795A3 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 07/31/2008 | WO2008045267A3 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 07/31/2008 | WO2008036653A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/31/2008 | WO2008035365A3 Rna interference mediated inhibition of aurorakinase b and its combinations as anticancer therapy |
| 07/31/2008 | WO2008031061A3 Anti-activin a antibodies and uses thereof |
| 07/31/2008 | WO2008023283A3 Stabilized esters of lutein |
| 07/31/2008 | WO2008019366A3 Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens |
| 07/31/2008 | WO2008016793A3 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 07/31/2008 | WO2008008493A8 Alkyne-substituted pyridone compounds and methods of use |
| 07/31/2008 | WO2007141533A3 Fkbp-l and uses thereof |
| 07/31/2008 | WO2007134298A3 Therapeutic compounds and their use in cancer |
| 07/31/2008 | WO2007127010A3 Diarylthiohydantoin compounds |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182977 Molecules associated with cell proliferation |
| 07/31/2008 | US20080182975 Framework-Patched Immunoglobulins |
| 07/31/2008 | US20080182900 Method of treatment of virus infections using shikonin compounds |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182879 e.g. 6-hydroxy-2-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]chromone; tyrosine kinase inhibitors, anticarcinogenic and antiinflammatory agent; cerebral, genito-urinary tract, lymphatic system, stomach, laryngeal, pancreatic, breast or lung tumor; rheumatoid arthritis, psoriasis, contact dermatitis |
| 07/31/2008 | US20080182871 e.g. 3-(3-methoxyphenyl)isoquinolin-1-amine; antiproliferative and antigrowth agent; breast tumors, prostate tumors, colon tumors, ovary tumors, kidney tumors, pancreas tumors, glioblastoma and melanoma. |
| 07/31/2008 | US20080182867 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/31/2008 | US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer |
| 07/31/2008 | US20080182852 Anthranilamide inhibitors of aurora kinase |
| 07/31/2008 | US20080182844 7-Substituted Aza-Indazoles, Compositions Containing Same, Production Method and Use Thereof |
| 07/31/2008 | US20080182843 Mitotic Kinesin Inhibitors |
| 07/31/2008 | US20080182842 L-alanine derivatives as a5beta1 antagonists |
| 07/31/2008 | US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 07/31/2008 | US20080182837 New chemical compounds |
| 07/31/2008 | US20080182834 less toxic than the unassociated metal complex by hindering reactions in the blood stream; antitumor agents; platinum, palladium, gold amine inclusion compounds |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182816 Utilizing prodrug technique to couple polysaccharides containing galactose with a parent compound through different bridge linkage to derive conjugates; polysaccharide component protects 5-fluorouracil(5-FU) from absorption in the upper gastrointestinal tract, delivers the 5-FU to colorectal area |
| 07/31/2008 | US20080182807 gene therapy against tumors and cancer; expression vector includes insert into tumor an effective amount of polynucleotides encoding a functionally active p53, express p53 to first DNA damaging agent, contact tumor cell with first DNA damaging agent, and kill tumor cell |
| 07/31/2008 | US20080182803 extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders |
| 07/31/2008 | US20080182797 Short peptides comprising the amino acid sequence Cys-Glu-Phe-His as well as analogs and derivatives thereof, which peptides efficiently denitrate cellular proteins and thus prevent tissue damage associated with excess nitric oxide and its reactive species; protection against ischemia/reperfusion injury |
| 07/31/2008 | US20080182794 Methods for treating breast cancer using nrif3 related molecules |
| 07/31/2008 | US20080182791 Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor |
| 07/31/2008 | US20080182782 Truncated cytochrome c551 for use as therapeutic agents in prevention and treatment of viral infection and cell proliferative dsorders |
| 07/31/2008 | US20080182777 Regulation of cell migration and adhesion |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080181971 antibiotic; synergistic with one or more of 5-fluorouracil, bortezomib, camptothecin, carmustine, cisplatin, doxorubicin, etoposide, gemcitabine, methotrexate, and paclitaxel;anticarcinogenic ; human and veterinary medicine |
| 07/31/2008 | US20080181963 Dermatological/cosmetic gels comprising at least one retinoid and benzoyl peroxide |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181939 hydrolysis triggered, controlled release polymersome nano-system for delivering a cytotoxic, anticancer therapeutic active agent to cell; stable, synthetic, self-assembling, controlled release, polyethylene oxide-based vesicles; semi-permeable, thin-walled, amphiphilic, high molecular weight |
| 07/31/2008 | US20080181928 stent; coating comprising a dry film comprising at least one lipid bilayer and at least one pharmaceutically effective agent; Upon exposure to an aqueous fluid, liposomes are released |
| 07/31/2008 | US20080181891 Modified human igf-ir antibodies |
| 07/31/2008 | US20080181877 bioassay of forskolin or phorbol 12-myristate 13-acetate; increase sensitivity of the protein kinase A signalling pathway, increase insulin sensitivity, thermogenesis; obesity, type 2 diabetes, insulin resistance, hypertriglyceridemia, cancer, increase plasma levels of free fatty acids |
| 07/31/2008 | US20080181870 brain cancer treatment with a mixture of a viral vector and ganciclovir; delivered to target cells; provide prolong survival |
| 07/31/2008 | US20080181864 Reducing mitochondrial membrane potential in mammalian cell by administering an major histocompatibility complex (MHC) class II HLA-DR (human leukocyte antigen) ligand; control disease by manipulating mitochondrial metabolism; drug screening antitumor drug; treating human breast cancer |
| 07/31/2008 | US20080181852 water soluble polyglutamnylglutamine conjugated to drugs, polydentate ligands, targeting, optical imaging, magnetic resonance imaging or stabilizing agents, having improved bioavailability |
| 07/31/2008 | US20080181849 Methods, kits and compositions comprising crotamine |
| 07/31/2008 | US20080179246 Method of obtaining a natural hydroxytyrosol-rich concentrate from olive tree residues and subproducts using clean technologies |
| 07/31/2008 | DE102007010815B3 New N-phenylsulfonyl-3-amidino-phenylalanine piperidide derivatives useful as antitumor agents |
| 07/31/2008 | CA2676436A1 Diagnosis of prostate cancer |
| 07/31/2008 | CA2676413A1 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 07/31/2008 | CA2676387A1 Combination therapy |
| 07/31/2008 | CA2676257A1 Anthranilamide inhibitors of aurora kinase |
| 07/31/2008 | CA2676105A1 The tetracyclic anthraquinones possessing anti-cancer effect |
| 07/31/2008 | CA2676008A1 Compositions and methods for diagnosing and treating cancer |
| 07/31/2008 | CA2675621A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 07/31/2008 | CA2675293A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2675292A1 Cancerous disease modifying antibodies |